Disclaimer
is pocket guide attempts to define principles of practice that should produce high-quality
patient care. It is applicable to specialists, primary care, and providers at all levels. is
pocket guide should not be considered exclusive of other methods of care reasonably directed at
obtaining the same results. e ultimate judgment concerning the propriety of any course of
conduct must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
Abbreviations
AIDS, Acquired Immunodeficiency Syndrome; ASAM, American Society of Addiction
Medicine; BP, blood pressure; DSM-5, Diagnostic and Statistical Manual of Mental
Disorders, 5th Edition; FDA, Food and Drug Administration; HHS, U.S. Department
of Health & Human Services; HIV, Human Immunodeficiency Virus; mL, milliliter;
mg, milligram; NSAIDs, Non-Steroidal Anti-Inflammatory Drugs; OBOT, Office-
Based Opioid Treatment; OTP, Opioid treatment program; OUD, Opioid use disorder;
STI, Sexually transmitted infection; TB, Tuberculosis; UROD, Ultra-Rapid Opioid
Detoxification; WM, withdrawal management; XR, extended release
Source
e ASAM National Practice Guideline for the Treatment of Opioid Use Disorder:
2020 Focused Update. Available at: https://www.asam.org/Quality-Science/quality/
2020-national-practice-guideline
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2020 All rights reserved
ASAMOPI3203
Resources
1
e ASAM Criteria [https://www.asam.org/asam-criteria]
2
e ASAM Standards
[https://www.asam.org/resources/quality/standards-and-performance-measures]
3
e ASAM Sample Diversion Control Policy
[https://www.asam.org/docs/default-source/advocacy/sample-diversion-policy.pdf ]
4
e ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine
[https://www.asam.org/Quality-Science/quality/drug-testing ]
5
e Prescription Drug Monitoring Program
[https://www.cdc.gov/drugoverdose/pdmp/providers.html]
6
ASAM.GuidelineCentral.com for Calculators
Guideline Committee Members
Chinazo Cunningham, MD, MS, FASAM; Mark J. Edlund, MD, PhD; Marc Fishman,
MD, DFASAM; Adam J. Gordon, MD, MPH, FACP, DFASAM; Hendrée E. Jones, PhD
Kyle Kampman, MD, FASAM, Chair; Daniel Langleben, MD; Marjorie Meyer, MD
Sandra Springer, MD, FASAM; George Woody, MD; Tricia E. Wright, MD, MS,
FACOG, DFASAM; Stephen Wyatt, DO, FAOAAM, FASAM, Co-Chair
